Rehmann Capital Advisory Group’s ResMed RMD Stock Holding History

Rehmann Capital Advisory Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$21.6K	Buy	159 +36	+29%	+$4.72K	﹤0.01%	850
2019 Q2	$15.1K	Buy	123 +23	+23%	+$2.55K	﹤0.01%	1221
2019 Q1	$10.4K	Buy	100 +88	+733%	+$9.08K	﹤0.01%	1312
2018 Q4	$1.37K	Hold	12	–	–	﹤0.01%	1574
2018 Q3	$1.38K	Hold	12	–	–	﹤0.01%	1906
2018 Q2	$1.24K	Hold	12	–	–	﹤0.01%	1918
2018 Q1	$1K	Buy	+12	New	+$1.13K	﹤0.01%	1916

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Rehmann Capital Advisory Group's RMD Position: Q3 2019 in Review

Rehmann Capital Advisory Group increased its ResMed (RMD) stake by 29% in Q3 2019, buying an estimated $4.72K and bringing the position to 159 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #850.

Rehmann Capital Advisory Group first reported a position in RMD in Q1 2018 and has held it in 7 quarters since. 527 funds tracked by Wall St. Rank hold RMD as of Q3 2019.

Rehmann Capital Advisory Group held 159 shares of ResMed worth $21.6K as of Q3 2019.
Rehmann Capital Advisory Group bought 36 ResMed shares in Q3 2019, an estimated $4.72K.
ResMed made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #850 holding.
Rehmann Capital Advisory Group first reported a position in ResMed in Q1 2018 and has held it in 7 quarters since.
527 funds tracked by Wall St. Rank held ResMed as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.